Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
2023-05-12 12:33:05 ET Cipher Pharmaceuticals Inc. (CPHRF) Q1 2023 Earnings Conference Call May 12, 2023 8:30 am ET Corporate Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants Dou...
2023-05-11 17:53:13 ET Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q1 GAAP EPS of $0.10 beats by $0.02 . Revenue of $4.9M (-9.3% Y/Y) misses by $0.64M . For further details see: Cipher Pharmaceuticals GAAP EPS of $0.10 beats by $0.02, revenue of $4....
2023-03-17 11:48:04 ET Cipher Pharmaceuticals Inc. (CPHRF) Q4 2022 Earnings Conference Call March 17, 2023 08:30 ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants Doug ...
Cipher Pharmaceuticals Inc. (CPHRF) Q3 2022 Earnings Conference Call November 11, 2022 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer David Miller - Director, Finance Conference Call Part...
Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q3 GAAP EPS of $0.11. Revenue of $4.8M (+6.7% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of $0.11, revenue of $4.8M
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2022 Earnings Conference Call August 12, 2022, 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer David Miller - Director, Finance Conference Call Par...
Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q2 GAAP EPS of $0.08. Revenue of $5.6M (-8.2% Y/Y) misses by $0.8M . For further details see: Cipher Pharmaceuticals GAAP EPS of $0.08, revenue of $5.6M misses by $0.8M
Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q1 GAAP EPS of C$0.08. Revenue of C$5.4M (flat Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.08, revenue of C$5.4M
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2021 Earnings Conference Call March 18, 2022, 8:30 AM ET Company Participants Craig Mull – Interim Chief Executive Officer Scott Langille – Chief Financial Officer David Miller – Director, Finance Conference Call Participants Andre U...
Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q4 GAAP EPS of C$0.11. Revenue of C$5.9M (-3.3% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.11, revenue of C$5.9M
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Companhia Siderurgica Paulista Nova Cosipa Website:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...